WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1117

Legislative bill overview

SB 1117 would authorize dentists in Texas to administer botulinum toxin (Botox) injections as part of their dental practice. Currently, this procedure is restricted to physicians, physician assistants, and nurse practitioners. The bill expands the scope of practice for licensed dentists to include cosmetic and therapeutic botulinum toxin administration.

Why is this important

This legislation affects healthcare access and consumer choice by potentially increasing the availability and accessibility of botulinum toxin treatments while potentially reducing costs through expanded provider options. It also raises questions about professional licensing standards, patient safety oversight, and the training requirements necessary for dentists to safely administer neurotoxin injections outside their traditional scope of practice.

Potential points of contention

  • Patient safety and training standards: Concerns about whether dental school curricula adequately prepare dentists for administering neurotoxins, potential complications, and adverse event reporting compared to physicians with different medical training
  • Professional scope creep: Questions about whether expanding dentist authority into cosmetic procedures dilutes professional boundaries and whether dentists should focus on oral health rather than facial aesthetics
  • Regulatory oversight and liability: Disputes over which regulatory bodies (dental vs. medical boards) would oversee these injections, manage complaints, and establish continuing education requirements; questions about malpractice insurance coverage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.